Objective: Identify the effect of ultrathin drug eluting stents on long term outcomes in coronary artery disease.
Background: Although second-generation drug eluting stents (DES) are superior to first-generation DES, persistence of adverse outcomes has led to continued refinement in design. Ultrathin second-generation DES have been shown to improve outcomes at 1-year follow-up.